James D. Dondero, 10% Owner at Paratek Pharmaceuticals, Inc. (PRTK), bought 1,128,500 shares at $1.77 ($1.8M) on 2023-03-22, disclosed to the SEC on 2023-03-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.50 | 234,863 | $352K | 19.8% |
| 2 | $1.50 | 234,863 | $352K | 19.8% |
| 3 | $1.40 | 105,137 | $147K | 8.3% |
| 4 | $1.40 | 105,137 | $147K | 8.3% |
| 5 | $1.74 | 242,500 | $422K | 23.7% |
| 6 | $1.77 | 106,000 |
| $188K |
| 10.5% |
| 7 | $1.73 | 100,000 | $173K | 9.7% |
| Total | $1.58 avg | 1,128,500 | $1.8M | 100% |
| Filing → |
| NXDT | BUY | 2025-04-14 | $408K | — | Filing → |
| NXDT | BUY | 2024-10-09 | $124K | — | Filing → |
| NXDT | BUY | 2024-07-01 | $268K | — | Filing → |